We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GMED market cap is 7.83B. The company's latest EPS is USD 0.7607 and P/E is 76.00.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 606.7M | 629.69M | 625.71M | 657.29M | 598.12M |
| Operating Income | 8M | 49.65M | 48.1M | 60.27M | 97M |
| Net Income | -7.12M | 31.76M | 51.84M | 26.51M | 75.46M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 789.04M | 958.1M | 1.02B | 1.57B | 2.52B |
| Operating Income | 111.43M | 177.87M | 230.29M | 133.14M | 165.99M |
| Net Income | 102.29M | 149.19M | 190.17M | 122.87M | 102.98M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.94B | 4.99B | 5.09B | 5.25B | 4.71B |
| Total Liabilities | 1.02B | 1.02B | 1.02B | 1.07B | 623.08M |
| Total Equity | 3.92B | 3.98B | 4.07B | 4.18B | 4.09B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.68B | 1.96B | 2.08B | 5.09B | 5.25B |
| Total Liabilities | 173.19M | 215.88M | 229.75M | 1.09B | 1.07B |
| Total Equity | 1.51B | 1.74B | 1.85B | 4B | 4.18B |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 52.39M | 106.65M | 330.27M | 520.64M | 177.3M |
| Investing | -46.58M | -56.96M | -71.93M | -176.05M | 131.39M |
| Financing | -115.72M | -107.01M | -87.43M | -27.7M | -635.4M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 198.79M | 276.27M | 178.47M | 243.5M | 520.64M |
| Investing | -117.32M | -375.94M | -110.36M | 302.97M | -176.05M |
| Financing | -38.66M | 54.15M | -109.96M | -231.82M | -27.7M |
| Market Cap | 7.83B |
| Price to Earnings Ratio | 76.00 |
| Price to Sales Ratio | 3.11 |
| Price to Cash Ratio | 9.98 |
| Price to Book Ratio | 1.87 |
| Dividend Yield | - |
| Shares Outstanding | 135.38M |
| Average Volume (1 week) | 1.39M |
| Average Volume (1 Month) | 1.1M |
| 52 Week Change | -13.26% |
| 52 Week High | 94.93 |
| 52 Week Low | 54.48 |
| Spread (Intraday) | 4.21 (7.01%) |
| Company Name | Globus Medical Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.globusmedical.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
